| 1 |
Castaño C, Novials A, Párrizas M. Exosomes from Short-Term High-Fat or High-Sucrose Fed Mice Induce Hepatic Steatosis through Different Pathways. Cells 2022;12. [PMID: 36611962 DOI: 10.3390/cells12010169] [Reference Citation Analysis]
|
| 2 |
El Meouchy P, Wahoud M, Allam S, Chedid R, Karam W, Karam S. Hypertension Related to Obesity: Pathogenesis, Characteristics and Factors for Control. Int J Mol Sci 2022;23:12305. [PMID: 36293177 DOI: 10.3390/ijms232012305] [Reference Citation Analysis]
|
| 3 |
Gjorgjieva M, Ay A, Correia de Sousa M, Delangre E, Dolicka D, Sobolewski C, Maeder C, Fournier M, Sempoux C, Foti M. MiR-22 Deficiency Fosters Hepatocellular Carcinoma Development in Fatty Liver. Cells 2022;11:2860. [DOI: 10.3390/cells11182860] [Reference Citation Analysis]
|
| 4 |
Sobolewski C, Dubuquoy L, Legrand N. MicroRNAs, Tristetraprolin Family Members and HuR: A Complex Interplay Controlling Cancer-Related Processes. Cancers 2022;14:3516. [DOI: 10.3390/cancers14143516] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 5 |
Li W, Yuan X, He X, Yang L, Wu Y, Deng X, Zeng Y, Hu K, Tang B. The downregulation of miR-22 and miR-372 may contribute to gestational diabetes mellitus through regulating glucose metabolism via the PI3K/AKT/GLUT4 pathway. J Clin Lab Anal 2022;:e24557. [PMID: 35712865 DOI: 10.1002/jcla.24557] [Reference Citation Analysis]
|
| 6 |
Abdullah AS, Sayed IETE, El-Torgoman AMA, Kalam A, Wageh S, Kamel MA. Green Synthesis of Silymarin-Chitosan Nanoparticles as a New Nano Formulation with Enhanced Anti-Fibrotic Effects against Liver Fibrosis. Int J Mol Sci 2022;23:5420. [PMID: 35628233 DOI: 10.3390/ijms23105420] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 7 |
Dolicka D, Zahoran S, Correia de Sousa M, Gjorgjieva M, Sempoux C, Fournier M, Maeder C, Collart MA, Foti M, Sobolewski C. TIA1 Loss Exacerbates Fatty Liver Disease but Exerts a Dual Role in Hepatocarcinogenesis. Cancers 2022;14:1704. [DOI: 10.3390/cancers14071704] [Reference Citation Analysis]
|
| 8 |
Yang L, Du W, Zheng Z, Wang L, Xiao L, Yang Q, Hao Q, Zhou J, Du J, Li J, Valencia CA, Dong B, Chow HY, Fu X, Dong B. Optimization of miR-22 expression cassette for rAAV delivery on diabetes. Mol Biomed 2022;3:1. [PMID: 34984525 DOI: 10.1186/s43556-021-00063-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 9 |
Abdullah AS, El Sayed IET, El-Torgoman AMA, Alghamdi NA, Ullah S, Wageh S, Kamel MA. Preparation and Characterization of Silymarin-Conjugated Gold Nanoparticles with Enhanced Anti-Fibrotic Therapeutic Effects against Hepatic Fibrosis in Rats: Role of MicroRNAs as Molecular Targets. Biomedicines 2021;9:1767. [PMID: 34944582 DOI: 10.3390/biomedicines9121767] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 10 |
Huang Y, Liu HM, Mao QY, Cong X, Zhang Y, Lee SW, Park K, Wu LL, Xiang RL, Yu GY. High Glucose Reduces the Paracellular Permeability of the Submandibular Gland Epithelium via the MiR-22-3p/Sp1/Claudin Pathway. Cells 2021;10:3230. [PMID: 34831451 DOI: 10.3390/cells10113230] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 11 |
Wu Z, Geng J, Bai Y, Qi Y, Chang C, Jiao Y, Guo Z. MicroRNA-22 inhibition promotes the development of atherosclerosis via targeting interferon regulator factor 5. Exp Cell Res 2021;409:112922. [PMID: 34780785 DOI: 10.1016/j.yexcr.2021.112922] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
